Efficacy Study of Pembrolizumab With Entinostat to Treat Metastatic Melanoma of the Eye
Clinical trial NCT02697630 · COMPLETED
Trial details
- NCT number
- NCT02697630
- Sponsor
- Vastra Gotaland Region
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-21
- Primary completion
- 2023-01-31
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.